People | February 28, 2026
Lupin’s Vinita Gupta honoured as CNBC Changemaker for revolutionising U.S. healthcare access
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
The presentation will provide qualitative insights into its safety, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity in patients with solid tumors
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
Tolvaptan Tablets are indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Subscribe To Our Newsletter & Stay Updated
